Pathstone Family Office’s iShares US Healthcare ETF IYH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$470K Buy
8,705
+4,815
+124% +$269K ﹤0.01% 1068
2023
Q2
$218K Buy
3,890
+15
+0.4% +$834 ﹤0.01% 1108
2023
Q1
$212K Sell
3,875
-3,875
-50% -$213K ﹤0.01% 1064
2022
Q4
$440K Sell
7,750
-8,000
-51% -$441K ﹤0.01% 1156
2022
Q3
$796K Buy
15,750
+7,875
+100% +$425K 0.01% 859
2022
Q2
$424K Buy
+7,875
New +$432K 0.01% 648
2021
Q1
Sell
-55
Closed -$3K 1001
2020
Q4
$3K Buy
+55
New +$2.6K ﹤0.01% 996

Other funds holding IYH

Pathstone Family Office's IYH Position: Q3 2023 in Review

Pathstone Family Office increased its iShares US Healthcare ETF (IYH) stake by 124% in Q3 2023, buying an estimated $269K and bringing the position to 8,705 shares worth $470K. The position accounts for ﹤0.01% of the portfolio, ranked #1068.

Pathstone Family Office first reported a position in IYH in Q4 2020 and has held it in 7 quarters since. The position peaked at $796K in Q3 2022. 475 funds tracked by Wall St. Rank hold IYH as of Q3 2023.

  • Pathstone Family Office held 8,705 shares of iShares US Healthcare ETF worth $470K as of Q3 2023.
  • Pathstone Family Office bought 4,815 iShares US Healthcare ETF shares in Q3 2023, an estimated $269K.
  • iShares US Healthcare ETF made up ﹤0.01% of Pathstone Family Office's portfolio in Q3 2023, its #1068 holding.
  • Pathstone Family Office first reported a position in iShares US Healthcare ETF in Q4 2020 and has held it in 7 quarters since.
  • Pathstone Family Office's iShares US Healthcare ETF position peaked at $796K in Q3 2022.
  • 475 funds tracked by Wall St. Rank held iShares US Healthcare ETF as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.